Cyclica

We have officially been acquired by @RecursionPharma! Follow Recursion's accounts below to join us as we industrialize #drugdiscovery as one team. ✅ Twitter - @RecursionPharma ✅ LinkedIn - bit.ly/45H4tOj ✅ YouTube - bit.ly/3C22CWL (1/2)

Predicting protein targets for ~36 billion compounds takes a massive team effort. We sat down with our VP of #digitalchemistry @ss_mackinnon to learn more about what went into accomplishing this feat. Read more: recursion.com/news/a-deep-di… #biotech #artificialintelligence #AlphaFold #deeplearning #chemistry #techbio #ML #AI

#BREAKING: We bridged the protein and chemical space by predicting the protein target(s) for ~36 billion compounds in the @EnamineLtd REAL Space using @nvidia’s DGX Cloud and our own NVIDIA-based supercomputer, BioHive-1. Learn more: ir.recursion.com/news-releases/… (1/3)

With the unveiling of Valence Labs (@valence_ai), our new #ML research center, we are doubling down on our commitment to open science by dedicating this team to building the ML community through data, tool and infrastructure releases. And we are kicking things off by committing up to $1M to support academic research at the intersection of bio, chem and #AI. Learn more: ir.recursion.com/news-releases/…

#ICYMI - Our #CTO, Ben Mabey (@bmabey), wrote a #blog that takes a deep dive into our recent @nvidia collaboration & how it marks a significant milestone on our journey toward revolutionizing #drugdiscovery through #AI. Read it here: bit.ly/44pFy0y #nvidia $NVDA #techbio #ai #biotech

Today we announced a collaboration and $50 million investment from @nvidia to accelerate our groundbreaking foundation models in AI-enabled drug discovery. Read the press release: ir.recursion.com/news-releases/… Read the blog from our CTO @bmabey: recursion.com/news/recursion…

Great to see this informative article from Chemical & Engineering News (@cenmag) about how #AI-derived breakthroughs in drug #research are spurring change across the pharmaceutical industry. We are proud to see it feature @RecursionPharma, our partner @genentech, our acquisitions of @Cyclica & @valence_ai, & others in the #techbio space. Read more below ⬇️

It’s that time of the year again — Recursion Summer Break! Every year over the holidays & 4th of July week, we close the office to rest and recharge. We’ll be back from our company-wide break on Monday, July 10th! #outsideRecursion #summerbreak #OOO

It's been a fantastic morning celebrating the official opening of our #Toronto office alongside members of Canada's #techbio community. We're thrilled to be placing roots in this vibrant and welcoming tech & research hub. Thanks to Hon. @SeanFraserMP, Premier @fordnation, Hon. @VictorFedeli, @Toronto_Global & Deputy Mayor @McKelvieTO for joining us at the event. Learn more: ir.recursion.com/news-releases/…

Appreciated attending the opening of Recursion Canada’s HQ in Toronto. Congrats to dear friend @naheedkurji on his leadership of @Cyclica & new role at @RecursionPharma. Thx to Recursion for choosing to invest in Toronto. No better place to find talent in AI & life sciences.

🆕Hot off the press! This paper from @HalabelianLab in collaboration with @RecursionPharma is a great example of how AI-enabled virtual screening methods can accelerate drug discovery efforts. Read how they identified ligands for the DCAF1 WDR domain: bit.ly/3CHF75k

Co-founder & CEO @RecursionChris spoke with @Nature about our approach to applying #ai and #machinelearning in cellular imaging to decode #biology. Read the story to learn more: go.nature.com/43iqpxn #biotech #techbio

Today we announced that our Phase 2 trial of REC-994 for the potential treatment of Cerebral Cavernous Malformations (#CCM) has reached full enrollment. Learn more: ir.recursion.com/news-releases/…

We’re excited to announce we have successfully predicted the protein target for every molecule in our compound library using @Cyclica’s technology! That’s >1M compounds profiled in a matter of weeks since closing the acquisition, with a merged dataset leading us to many new insights. Stay tuned for more!

Great segment from @SquawkCNBC about #AI in #drugdiscovery this morning! Thanks to @ScottGottliebMD for including us in the conversation. Watch ⬇️ #biotech #techbio

On the tails of acquiring @Cyclica and @valence_ai this past month, co-founder & #CEO @RecursionChris spoke with @ClinicalLeader1 to share more about the agreements, the rapidly changing #techbio space, our commitment to patients and more. Read: bit.ly/3OX5trz #ai #ml #biotech

Thanks to all the @BioHiveUtah folks who showed up to support the #SLC #LGBTQ+ community at #Pride this weekend! We had a ton of fun walking in the parade — we’re already looking forward to next year. 🏳️‍🌈❤️

We’re thrilled to congratulate our Board Chairperson, @RMartinChavez, on his recognition as a #biopharma leader paving the way for #LGBTQ+ #scientists, patients, #entrepreneurs & C-suites by @endpts. Learn more about Martin: bit.ly/3ClDhqB

We are honoured to have been listed as one of the 'Top Ontario biotech companies to watch in 2023' by @investontario! As we enter into a new chapter of #drugdiscovery as @RecursionPharma, we are committed to continuing our work in advancing the #AI healthcare ecosystem in #Ontario and delivering #innovative medicines to patients. #techbio #healthcare #biotech #Toronto #pharma

As we promote Ontario's #LifeSciences @BIOConvention check out the #Top10 #biotech companies to watch in 2023: @Cyclica, @deepgenomics, @Microbix, @OmniaBio, @proteinqure, @Roche, @sanofi, @Triumvirainc & @VervTec: investontario.ca/spotlights/top… #BIO2023

Help spread the word and share the above post with your followers/networks! #techbio #SocialMedia #SocialChannels #biotech #pharma (2/2)

We have officially been acquired by @RecursionPharma! Follow Recursion's accounts below to join us as we industrialize #drugdiscovery as one team. ✅ Twitter - @RecursionPharma ✅ LinkedIn - bit.ly/45H4tOj ✅ YouTube - bit.ly/3C22CWL (1/2)